<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38504716</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Severe COVID-19 and its cardiopulmonary effects 6 and 18 months after hospital discharge.</ArticleTitle><Pagination><StartPage>1366269</StartPage><MedlinePgn>1366269</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1366269</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2024.1366269</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">SARS-CoV-2 infection affects the cardiopulmonary system in the acute as well as long-term phase. The aim of the present study was to comprehensively assess symptoms and possible long-term impairments 6 and 18 months after hospitalization for severe COVID-19 infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This prospective registry included patients with PCR-confirmed COVID-19 infection requiring hospitalization. Follow-up approximately 6 months post discharge comprised a detailed patient history, clinical examination, transthoracic echocardiography, electrocardiogram, cardiac magnetic resonance imaging (cMRI), chest computed tomography (CT) scan, pulmonary function test (PFT), six-minute walk test (6MWT) and a laboratory panel. At the time of the second follow-up visit at 18 months, patients without pathologic findings during the first study visit were contacted by phone to inquire about the course of their symptoms. In all other patients all initial examinations were repeated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Two hundred Patients, who were hospitalized for COVID-19, were contacted by phone and were recruited for the study. Due to dropouts the second study visit was performed in 170 patients. A comparison between the two study visits at 6 and 18 months post discharge showed the following results: Six months after discharge, 73% and 18 months after discharge 52% fulfilled the criteria for Long COVID with fatigue being the most common symptom (49%). Echocardiography at 6 months post discharge showed an impaired left ventricular function in 8% of which 80% returned to normal. Six months post discharge, cMRI revealed pericardial effusion in 17% which resolved in 47% of the 15 patients who underwent a control cMRI. Signs of peri- or myocarditis were present in 5% of the patients and were resolved in all 4 patients who attended control studies. At 6 months, chest CT scans identified post-infectious residues in 24%. In the 25 repeated chest CT scans 20% showed full recovery. Length of in-hospital stay was identified as a significant predictor for persisting Long COVID (95% CI: 1.005-1.12, <i>p</i>&#x2009;=&#x2009;0.03).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Comparing 6 to 18 months, the prevalence of Long COVID decreased over time, but a high symptom burden remained. Structural and functional abnormalities were less frequent than the portrayed symptoms, and it thus remains a challenge to substantiate the symptoms.</AbstractText><CopyrightInformation>&#xa9; 2024 Niebauer, Iscel, Schedl, Capelle, Kahr, Schamilow, Faltas, Srdits, Badr-Eslam, Lichtenauer, Zoufaly, Valenta, Hoffman, Charwat-Resl, Krestan, Hitzl, Wenisch and Bonderman.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Niebauer</LastName><ForeName>J H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Emergency Medicine, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iscel</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Emergency Medicine, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schedl</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Emergency Medicine, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capelle</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Emergency Medicine, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahr</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, AKH Wien, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schamilow</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Emergency Medicine, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faltas</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Emergency Medicine, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srdits</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Emergency Medicine, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badr-Eslam</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, AKH Wien, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichtenauer</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoufaly</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Sigmund Freud University, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valenta</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Emergency Medicine, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charwat-Resl</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Emergency Medicine, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krestan</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiology, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hitzl</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Research and Innovation Management (RIM), Team Biostatistics and Publication of Clinical Trial Study, Paracelsus Private Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology and Optometry, Paracelsus Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Program Experimental Ophthalmology and Glaucoma Research, Paracelsus Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wenisch</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonderman</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Emergency Medicine, Klinik Favoriten, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">heart</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">long-term impairment</Keyword><Keyword MajorTopicYN="N">lung</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision. The reviewers [RZ, GH] declared a shared affiliation with the author [RBE] to the handling editor at the time of review.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>20</Day><Hour>3</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38504716</ArticleId><ArticleId IdType="pmc">PMC10948598</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2024.1366269</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sewanan LR, Clerkin KJ, Tucker NR, Tsai EJ. How does COVID-19 affect the heart? Curr Cardiol Rep. (2023) 25:171&#x2013;84. 10.1007/s11886-023-01841-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-023-01841-6</ArticleId><ArticleId IdType="pmc">PMC9999058</ArticleId><ArticleId IdType="pubmed">36897483</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Izquierdo M, Lainez-Ramos-Bossini AJ, de Alba IG-F, Ortiz-Gonz&#xe1;lez-Serna R, Serrano-Ortiz A, Fern&#xe1;ndez-Mart&#xed;nez NF, et al. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes&#x2014;a multicentre cohort study. BMC Med. (2022) 20:92. 10.1186/s12916-022-02292-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02292-6</ArticleId><ArticleId IdType="pmc">PMC8863509</ArticleId><ArticleId IdType="pubmed">35193574</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine. (2023) 41:1783&#x2013;90. 10.1016/j.vaccine.2023.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Kulzhabayeva D, Rodrigues NB, Di Vincenzo JD, Gill H, Subramaniapillai M, et al. COVID-19 vaccination for the prevention and treatment of long COVID: a systematic review and meta-analysis. Brain Behav Immun. (2023) 111:211&#x2013;29. 10.1016/j.bbi.2023.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.03.022</ArticleId><ArticleId IdType="pmc">PMC10067136</ArticleId><ArticleId IdType="pubmed">36990297</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli C, Zocchi C, Tassetti L, Silverii MV, Amato C, Livi L, et al. Factors associated with persistence of symptoms 1 year after COVID-19: a longitudinal, prospective phone-based interview follow-up cohort study. Eur J Intern Med. (2022) 97:36&#x2013;41. 10.1016/j.ejim.2021.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.11.018</ArticleId><ArticleId IdType="pmc">PMC8648678</ArticleId><ArticleId IdType="pubmed">34903448</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. (2021) 18:e1003773. 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12&#x2009;months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Med. (2022) 20:244. 10.1186/s12916-022-02448-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang O, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. (2021) 398:747&#x2013;58. 10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M, Alcaide P, Asselbergs FW, Brundel B, Camici GG, da Costa Martins P, et al. Long COVID and the cardiovascular system&#x2014;elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint scientific statement of the ESC working groups on cellular biology of the heart and myocardial and pericardial diseases. Cardiovasc Res. (2023) 119:336&#x2013;56. 10.1093/cvr/cvac115</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac115</ArticleId><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Mu&#xf1;iz MM, Arias &#xe1;, Mata-V&#xe1;zquez E, Mart&#xed;n-Toledano M, L&#xf3;pez-Larramon G, Ruiz-Chicote AM, et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. (2021) 10:2945. 10.3390/jcm10132945</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132945</ArticleId><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebauer JH, Binder-Rodriguez C, Iscel A, Schedl S, Capelle C, Kahr M, et al. Cardiopulmonary long-term sequelae in patients after severe COVID-19 disease. J Clin Med. (2023) 12:1536. 10.3390/jcm12041536</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12041536</ArticleId><ArticleId IdType="pmc">PMC9959779</ArticleId><ArticleId IdType="pubmed">36836071</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich MG, Cooper LT. What we (don&#x2019;t) know about myocardial injury after COVID-19. Eur Heart J. (2021) 42:1879&#x2013;82. 10.1093/eurheartj/ehab145</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab145</ArticleId><ArticleId IdType="pmc">PMC8108615</ArticleId><ArticleId IdType="pubmed">33713116</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:811. 10.1001/jamacardio.2020.1017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudot G, Chocron R, Augy J-L, Gendron N, Khider L, Debuc B, et al. Predictive factor for COVID-19 worsening: insights for high-sensitivity troponin and D-dimer and correlation with right ventricular afterload. Front Med (Lausanne). (2020) 7:8. 10.3389/fmed.2020.586307</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.586307</ArticleId><ArticleId IdType="pmc">PMC7689153</ArticleId><ArticleId IdType="pubmed">33282891</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan. China. JAMA Cardiol. (2020) 5:802. 10.1001/jamacardio.2020.0950</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. Journal of Infection. (2020) 80:639&#x2013;45. 10.1016/j.jinf.2020.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.019</ArticleId><ArticleId IdType="pmc">PMC7118526</ArticleId><ArticleId IdType="pubmed">32240670</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassar MP, Tunnicliffe EM, Petousi N, Lewandowski AJ, Xie C, Mahmod M, et al. Symptom persistence despite improvement in cardiopulmonary health &#x2013; insights from longitudinal CMR, CPET and lung function testing post-COVID-19. EClinicalMedicine. (2021) 41:101159. 10.1016/j.eclinm.2021.101159</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101159</ArticleId><ArticleId IdType="pmc">PMC8527025</ArticleId><ArticleId IdType="pubmed">34693230</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, et al. Post-acute COVID-19 syndrome. Eur Respir Rev. (2022) 31:210185. 10.1183/16000617.0185-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. (2021) 9:747&#x2013;54. 10.1016/S2213-2600(21)00174-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. (2022) 43:1157&#x2013;72. 10.1093/eurheartj/ehac031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiese A, Frati P, Del Duca F, Santoro P, Manetti AC, La Russa R, et al. Myocardial pathology in COVID-19-associated cardiac injury: a systematic review. Diagnostics (Basel). (2021) 11:9&#x2013;11. 10.3390/diagnostics11091647</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11091647</ArticleId><ArticleId IdType="pmc">PMC8472043</ArticleId><ArticleId IdType="pubmed">34573988</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten J, Wolf A, Hoyo L, H&#xfc;ll E, Tadic M, Andre&#x3b2; S, et al. Symptom burden correlates to impairment of diffusion capacity and exercise intolerance in long COVID patients. Sci Rep. (2022) 12:8801. 10.1038/s41598-022-12839-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-12839-5</ArticleId><ArticleId IdType="pmc">PMC9130688</ArticleId><ArticleId IdType="pubmed">35614108</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, Sun K, Tahir P, Peluso MJ, Deeks SG, Aras MA, et al. Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults. JAMA Netw Open. (2022) 5:e2236057. 10.1001/jamanetworkopen.2022.36057</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.36057</ArticleId><ArticleId IdType="pmc">PMC9557896</ArticleId><ArticleId IdType="pubmed">36223120</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rster C, Colombo MG, Wetzel A-J, Martus P, Joos S. Persisting symptoms after COVID-19. Dtsch Arztebl Int. (2022) 199:167. 10.3238/arztebl.m2022.0147</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0147</ArticleId><ArticleId IdType="pmc">PMC9215272</ArticleId><ArticleId IdType="pubmed">35236547</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob L, Koyanagi A, Smith L, Tanislav C, Konrad M, van der Beck S, et al. Prevalence of, and factors associated with, long-term COVID-19 sick leave in working-age patients followed in general practices in Germany. Int J Infect Dis. (2021) 109:203&#x2013;8. 10.1016/j.ijid.2021.06.063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.06.063</ArticleId><ArticleId IdType="pmc">PMC8922990</ArticleId><ArticleId IdType="pubmed">34224870</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. (2021) 53:737&#x2013;54. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, et al. A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis. (2022) 22:e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID&#x2014;mechanisms, risk factors, and management. BMJ. (2021) 374:n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. (2021) 6:100122. 10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Taylor S. NICE guideline on long COVID. Br Med J. (2020) 371:m4938. 10.1136/bmj.m4938</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla A, Ankermann T, Behrends U. S1-Leitlinie Long/ Post-COVID. AWMF online (2022). (accessed October 5, 2023).</Citation></Reference><Reference><Citation>Pel&#xe0; G, Goldoni M, Cavalli C, Perrino F, Tagliaferri S, Frizelli A, et al. Long-term cardiac sequelae in patients referred into a diagnostic post-COVID-19 pathway: the different impacts on the right and left ventricles. Diagnostics. (2021) 11:2059. 10.3390/diagnostics11112059</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11112059</ArticleId><ArticleId IdType="pmc">PMC8623572</ArticleId><ArticleId IdType="pubmed">34829406</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Tarbsheh AH, Leamon A, Chong WH, Chung JK, Oweis J, Vamshek S, et al. Pericardial effusion in COVID-19 patients. Am J Med Sci. (2022) 364:129&#x2013;30. 10.1016/j.amjms.2022.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2022.01.024</ArticleId><ArticleId IdType="pmc">PMC9110270</ArticleId><ArticleId IdType="pubmed">35276074</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Xie J, Gao P, Tian R, Qian H, Guo F, et al. Swollen heart in COVID-19 patients who progress to critical illness: a perspective from echo-cardiologists. ESC Heart Fail. (2020) 7:3621&#x2013;32. 10.1002/ehf2.12873</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12873</ArticleId><ArticleId IdType="pmc">PMC7646648</ArticleId><ArticleId IdType="pubmed">32977359</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmottaleb W, Salmon JT, Quintanilla Rodriguez BS, Portillo I, Mushiyev S. COVID-19 myopericarditis with pericardial effusion complicated with cardiac tamponade and rhabdomyolysis. Cureus. (2022) 14(7):1. 10.7759/cureus.27291</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.27291</ArticleId><ArticleId IdType="pmc">PMC9403220</ArticleId><ArticleId IdType="pubmed">36039245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammirati E, Lupi L, Palazzini M, Hendren NS, Grodin JL, Cannistraci CV, et al. Prevalence, characteristics, and outcomes of COVID-19&#x2013;associated acute myocarditis. Circulation. (2022) 145:1123&#x2013;39. 10.1161/CIRCULATIONAHA.121.056817</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.056817</ArticleId><ArticleId IdType="pmc">PMC8989611</ArticleId><ArticleId IdType="pubmed">35404682</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar K, Ratnakumar R, Collin SM, Berrocal-Almanza LC, Ricci P, Al-Zubaidy M, et al. Chest CT features and functional correlates of COVID-19 at 3 months and 12 months follow-up. Clin Med (Lond). (2023) 23:467&#x2013;77. 10.7861/clinmed.2023-0059</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2023-0059</ArticleId><ArticleId IdType="pmc">PMC10541283</ArticleId><ArticleId IdType="pubmed">37775167</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C, et al. Outcomes among confirmed cases and a matched comparison group in the long-COVID in Scotland study. Nat Commun. (2022) 13:5663. 10.1038/s41467-022-33415-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33415-5</ArticleId><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A, Ara&#xfa;jo-Ameijeiras A, Fern&#xe1;ndez-Villar A, Crespo M, Poveda E, et al. Long COVID in hospitalized and non-hospitalized patients in a large cohort in northwest Spain, a prospective cohort study. Sci Rep. (2022) 12:3369. 10.1038/s41598-022-07414-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07414-x</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Scurati R, Papini N, Giussani P, Alberti G, Tringali C, et al. The challenge of long COVID-19 management: from disease molecular hallmarks to the proposal of exercise as therapy. Int J Mol Sci. (2022) 23:12311. 10.3390/ijms232012311</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232012311</ArticleId><ArticleId IdType="pmc">PMC9603679</ArticleId><ArticleId IdType="pubmed">36293160</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ, et al. The immunology of long COVID. Nat Rev Immunol. (2023) 23:618&#x2013;34. 10.1038/s41577-023-00904-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>